Medindia

X

Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease

Tuesday, June 22, 2010 Research News J E 4
Advertisement

Contacts:

Neurologix

Marc Panoff, 201-592-6451

Chief Financial Officer

marcpanoff@neurologix.net

Cohn & Wolfe

Jennifer Paganelli, 347-658-8290

Jennifer.Paganelli@cohnwolfe.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Probactive Biotech, Inc. Announces an Agreement to...
S
Coveo Announces Next Webinar: Enterprise Search 2....